Dr. James Li joined Kleiner Perkins Caufield & Byers in October 2006. Prior
to joining KPCB, James spent over 15 years of outstanding service with
Merck Co. where he held positions of increasing responsibility in basic
research, clinical research, regulatory affairs, new product
development/access and franchise management, all with an Asia Pacific
focus. James has been a known expert in the Asia Pacific
pharmaceutical industry. He has publish...
more
Dr. James Li joined Kleiner Perkins Caufield & Byers in October 2006.
Prior
to joining KPCB, James spent over 15 years of outstanding service with
Merck Co. where he held positions of increasing responsibility in basic
research, clinical research, regulatory affairs, new product
development/access and franchise management, all with an Asia Pacific
focus.
James has been a known expert in the Asia Pacific
pharmaceutical industry. He has published a number of papers on the
region’s clinical, regulatory access and marketing issues and has been
a regular speaker and guest consultant for a number of government
regulatory agencies, academic institutes and industry associations.
From
1996 to 2000, James was the Medical Director of Merck’s China
Operations, where he successfully developed a first class professional
medical team, conducted early phase clinical studies, and developed
strong relationships with government regulatory agencies, key opinion
leaders, and top research institutes.
In 2003, James was
appointed Regional Marketing Director, Hypertension, for the Asia
Region and successfully drove the fast growth of Merck’s largest
franchise in the region.
James received his Medical Degree from
Shanghai Medical University, completing an internship in Internal
Medicine and a rotation in Oncology, followed by a Master of Science
degree in Microbiology from the University of Montana.
